These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21854277)

  • 21. Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.
    Winhusen T; Brady KT; Stitzer M; Woody G; Lindblad R; Kropp F; Brigham G; Liu D; Sparenborg S; Sharma G; Vanveldhuisen P; Adinoff B; Somoza E
    Contemp Clin Trials; 2012 Sep; 33(5):993-1002. PubMed ID: 22613054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of urine drug screening in the medical clearance of pediatric psychiatric patients: is there one?
    Shihabuddin BS; Hack CM; Sivitz AB
    Pediatr Emerg Care; 2013 Aug; 29(8):903-6. PubMed ID: 23903675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of non-concordant self-report of substance use in clinical trials research.
    Clark CB; Zyambo CM; Li Y; Cropsey KL
    Addict Behav; 2016 Jul; 58():74-9. PubMed ID: 26921721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription Drug Monitoring Programs: Does the Arizona CSPMP Provide More Information than Routinely Collected in an Inpatient Psychiatric Facility?
    Sood S; Cowdrey A; Bhattarai B; Ayutyanont N; Ramos G; Khosla D; Willows B
    Subst Use Misuse; 2019; 54(1):106-109. PubMed ID: 30332337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Urine Drug Screening on No Shows and Dropouts among Chronic Pain Patients: A Propensity-Matched Cohort Study.
    Krishnamurthy P; Ranganathan G; Williams C; Doulatram G
    Pain Physician; 2016 Feb; 19(2):89-100. PubMed ID: 26815253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of objective data to identify risk for medication misuse and abuse: the inconsistency score.
    Hamill-Ruth RJ; Larriviere K; McMasters MG
    Pain Med; 2013 Dec; 14(12):1900-7. PubMed ID: 23947737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The validity of self-reported cocaine use in two groups of cocaine abusers.
    Hersh D; Mulgrew CL; Van Kirk J; Kranzler HR
    J Consult Clin Psychol; 1999 Feb; 67(1):37-42. PubMed ID: 10028207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders.
    Kelley AT; Incze MA; Baumgartner M; Campbell ANC; Nunes EV; Scharfstein DO
    Drug Alcohol Depend; 2024 Aug; 261():111368. PubMed ID: 38896944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment.
    Khatri UG; Aronowitz SV
    J Subst Abuse Treat; 2021 Apr; 123():108258. PubMed ID: 33358617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High on drugs: Multi-institutional pilot study examining the effects of substance use on acute pain management.
    Salottolo K; Peck L; Carrick M; Tanner A; Madayag R; McGuire E; Bar-Or D
    Injury; 2019 May; 50(5):1058-1063. PubMed ID: 30642622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment.
    DeMaria PA; Sterling R; Weinstein SP
    Am J Addict; 2000; 9(2):145-53. PubMed ID: 10934576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should Urine Drug Screen be Done Universally or Selectively in Palliative Care Patients on Opioids?
    Arthur J; Childers J; Del Fabbro E
    J Pain Symptom Manage; 2023 Dec; 66(6):e687-e692. PubMed ID: 37429531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Substance Abuse Programs on Positive Drug Screening Tests in Trauma Patients.
    Hale JV; Feyh AS; Weaver A; Murray J; Denning DA; Amiri F
    Am Surg; 2020 Dec; 86(12):1717-1720. PubMed ID: 32866027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of Three Screening Tools for Prenatal Substance Use.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin KE; Koszowski B; Mark K
    Obstet Gynecol; 2019 May; 133(5):952-961. PubMed ID: 30969217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.
    Trivedi MH; Greer TL; Grannemann BD; Church TS; Somoza E; Blair SN; Szapocznik J; Stoutenberg M; Rethorst C; Warden D; Ring KM; Walker R; Morris DW; Kosinski AS; Kyle T; Marcus B; Crowell B; Oden N; Nunes E
    Trials; 2011 Sep; 12():206. PubMed ID: 21929768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The construct and predictive validity of different approaches to combining urine and self-reported drug use measures among older adolescents after substance abuse treatment.
    Lennox R; Dennis ML; Ives M; White MK
    Am J Addict; 2006; 15 Suppl 1():92-101. PubMed ID: 17182424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.
    Strang J; Kelleher M; Mayet S; Day E; Hellier J; Byford S; Murphy C; McLennan B; Shearer J; Ryan E; Marsden J
    Health Technol Assess; 2019 Jan; 23(3):1-72. PubMed ID: 30702059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.